Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Benefit of Ethanol Sclerotherapy of Endometriomas Before Ovarian Stimulation on Pregnancy Rates in IVF/ICSI

NCT06878053 is registered in ClinicalTrials.gov with Poissy-Saint Germain Hospital as lead sponsor.

NCT NCT06878053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06878053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Benefit of Ethanol Sclerotherapy of Endometriomas Before Ovarian Stimulation on Pregnancy Rates in IVF/ICSI
Lead sponsor
Poissy-Saint Germain Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 1, 2025
Completion date
June 1, 2029
Enrollment
174 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

infertile women undergoing ivf or icsi